Chronic Erythropoietin Treatment Decreases Post-Infarct Myocardial Damage in Rats without Venous Thrombogenic Effect - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cardiology Année : 2009

Chronic Erythropoietin Treatment Decreases Post-Infarct Myocardial Damage in Rats without Venous Thrombogenic Effect

(1) , , , , , , (1)
1
Fabrice Prunier
  • Fonction : Auteur
  • PersonId : 992121
P. Pottier
  • Fonction : Auteur
R. Clairand
  • Fonction : Auteur
A. Mercier
  • Fonction : Auteur
Roger Hajjar
  • Fonction : Auteur
B. Planchon
  • Fonction : Auteur
Alain Furber
  • Fonction : Auteur
  • PersonId : 1045492

Résumé

Objectives: Whereas administration of erythropoietin (EPO) acutely after myocardial infarction (MI) reduces infarct size and chronic EPO therapy attenuates post-MI remodeling, the safety of chronic EPO therapy following MI is unknown. Therefore, we examined the thrombogenic effects of a chronic EPO therapy after MI.Methods: Rats underwent coronary occlusion followed by reperfusion. They were assigned to one of the following groups: EPO-A, single injection of EPO 5,000 U/kg at the time of reperfusion; EPO-C, injection of EPO 5,000 U/kg at the time of reperfusion followed by 300 U/kg/week; PBS-C, injection of vehicle only. After eight weeks of treatment they were exposed to a validated prethrombotic test based on partial stenosis of the inferior vena cava. Results: As compared to the rats receiving vehicle only, the rats treated with EPO exhibited a significant reduction in MI size (28.7 ± 2.1% and 25.8 ± 1.9 vs. 39.8 ± 3.0% in EPO-A, EPO-C and PBS-C, respectively; p < 0.05). Whereas the hematocrit was significantly increased in EPO-C (59.7 ± 2.0% vs. 44.7 ± 0.9% in EPO-A, p < 0.001), the proportion of rats in which a thrombus occurred was similar in all groups (p = 0.52). Conclusion: Chronic EPO therapy added to the single high dose of EPO injected acutely did not induce venous pro-thrombotic effect in rats.

Fichier non déposé

Dates et versions

hal-03405231 , version 1 (27-10-2021)

Identifiants

Citer

Fabrice Prunier, P. Pottier, R. Clairand, A. Mercier, Roger Hajjar, et al.. Chronic Erythropoietin Treatment Decreases Post-Infarct Myocardial Damage in Rats without Venous Thrombogenic Effect. Cardiology, 2009, 112 (2), pp.129 - 134. ⟨10.1159/000142723⟩. ⟨hal-03405231⟩

Collections

UNIV-ANGERS
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More